Background: To test the feasibility of magnetic resonance elastography (MRE) for assessing changes in pancreatic stiffness of obese adults administered an oral glucose load.

Methods: MRE scans were performed on 21 asymptomatic obese volunteers (BMI ≥ 27 kg/m) before and after receiving a 75-g oral glucose load, and repeated in 7 days without a glucose load. Shear waves at 40 and 60 Hz were introduced into the upper abdomen by a pneumatic drum driver (diameter of 12 cm). Two radiologists subjectively graded the overall quality of the wave images of the pancreas using a scale from 1 to 4, in which suboptimal image quality was considered to be scores of 1 and 2.

Results: Good inter-observer agreement was found for image quality at both frequencies (kappa = 0.805 for 40 Hz and 0.762 for 60 Hz). The median overall image quality score was significantly higher in 40 Hz than that of 60 Hz (4 versus 2). At 40 Hz, pancreatic stiffness in response to oral glucose had a decrease of 6.7% (pre vs post: 1.17 ± 0.13 kPa vs 1.08 ± 0.12 kPa; P < 0.001), whereas the change in stiffness was not significant at 60 Hz (pre vs post: 2.01 ± 0.21 kPa vs 2.02 ± 0.24 kPa; P = 0.695). Excellent intersession agreement was found for MRE acquisitions at 40 Hz with an overall intraclass correlation coefficient = 0.947 (95% confidence interval: 0.913-0.967).

Conclusion: MRE at 40 Hz provides good-quality wave images and high sensitivity to changes in the mechanical properties of pancreatic tissue in obese volunteers after an oral glucose load.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183057PMC
http://dx.doi.org/10.1016/j.mri.2018.04.019DOI Listing

Publication Analysis

Top Keywords

oral glucose
16
pancreatic stiffness
12
glucose load
12
image quality
12
stiffness response
8
response oral
8
obese adults
8
magnetic resonance
8
resonance elastography
8
glucose
5

Similar Publications

Background: This study aimed to investigate the effects of oral semaglutide on the changes in food preference of Japanese patients with type 2 diabetes.

Methods: This retrospective multicenter study included 75 patients with type 2 diabetes who received oral semaglutide. The primary outcome was the change in the score of brief-type self-administered diet history questionnaire (BDHQ) score 3 months after the initiation of oral semaglutide treatment.

View Article and Find Full Text PDF

Endocrine alterations in patients with pachydermoperiostosis.

J Clin Endocrinol Metab

January 2025

Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Context: Pachydermoperiostosis (primary hypertrophic osteoarthropathy, PHO) usually due to biallelic loss-of-function variants in HPGD and SLCO2A1, has some features overlapping with acromegaly and often referred to endocrinologists. A detailed endocrine assessment is not available for these patients.

Objective: To assess the genetic and endocrine characteristics of PHO patients referred to endocrine centres with a possible diagnosis of acromegaly.

View Article and Find Full Text PDF

The P2YR is activated by UDP and UDP glucose and is involved in many human inflammatory diseases. Based on the molecular docking analysis of currently reported P2YR antagonists and the crystallographic overlap study between PPTN and compound , a series of 3-substituted 5-amidobenzoate derivatives were designed, synthesized, and identified as promising P2YR antagonists. The optimal compound (methyl 3-(1-benzo[]imidazol-2-yl)-5-(2-(-tolyl) acetamido)benzoate, IC = 0.

View Article and Find Full Text PDF

Background: The prevalence of gestational diabetes mellitus (GDM) is dependent on the diagnostic criteria used and there is no consensus on screening methods and diagnostic criteria. The International Association for Diabetes in Pregnancy Study Group (IADPSG) recently put forward new diagnostic criteria and encourages its adoption worldwide. The aim of this study was to determine the incidence of GDM and to compare the foeto-maternal outcomes of women diagnosed with GDM in the Federal Medical Centre, Yenagoa using the WHO 1999 and IADPSG criteria.

View Article and Find Full Text PDF

Growth hormone (GH) secretion by the pituitary is regulated by stimulatory and inhibitory pathways such as growth hormone releasing hormone (GHRH) and somatostatin, respectively, being also modulated by different neurotransmitters acting at the hypothalamic/pituitary level. The pineal gland hormone melatonin regulates GH secretion in many mammals, including humans, although its role in modulating GH secretion has been debated. We describe the case of a young woman chronically taking melatonin for sleep disturbances, referring to her general practitioner for flushing that appeared just after starting melatonin intake.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!